🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: EVUSHELD

Found 21 matching trials

Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries

N/A

Study on Clinical Use of EVUSHELD (AZD7442) as Pre-exposure Prophylaxis in ...

Status

Completed

Location

Research Site

Start Date

2022-06-23

Trial ID

NCT05315323

Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19

PHASE4

Study hypothesis: the viral neutralizing monoclonal antibodies Tiksagevimab...

Status

Unknown

Location

Moscow City Clinical Hospital 52

Start Date

2022-08-18

Trial ID

NCT05982704

Treatments Being Tested

tixagevimab/cilgavimab 150+150 mg tixagevimab/cilgavimab 300+300 mg regdanvimab

Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL

PHASE2

Chronic lymphocytic leukaemia (CLL) is a common lymphoid malignancy affecti...

Status

Withdrawn

Location

Sunnybrook Health Sciences Cente

Start Date

2023-10

Trial ID

NCT05465876

Treatments Being Tested

EVUSHELD

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

PHASE3

If a treated cancer patient cannot make antibodies to a Severe Acute Respir...

Status

Terminated

Location

Compassionate Cancer Care Medical Group

Start Date

2022-06-03

Trial ID

NCT05438498

Treatments Being Tested

Evusheld (tixagevimab+cilgavimab) IM or IV

Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.

N/A

This prospective cohort of patients, receiving pre exposure prophylaxis by ...

Status

Completed

Location

Hôpital Avicenne

Start Date

2022-01-26

Trial ID

NCT05216588

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

N/A

Absence of anti-SARS-CoV-2 vaccine response or insufficient vaccine respons...

Status

Completed

Location

Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospital

Start Date

2021-08-01

Trial ID

NCT05439044

Treatments Being Tested

Data collection

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

PHASE2

The trial will develop and validate a platform for quantitative assessment ...

Status

Recruiting

Location

Universidade Federal de Minas Gerais

Start Date

2021-09-30

Trial ID

NCT05041907

Treatments Being Tested

Nirmatrelvir/ritonavir (e.g. PAXLOVID™)Nitazoxanide Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™)Hydroxychloroquine No treatment Monoclonal antibodies Fluoxetine Molnupiravir Sotrovimab Ensitrelvir Monoclonal antibodies Favipiravir Ivermectin Remdesivir Atilotrelvir/ritonavir Metformin Nirmatrelvir/ritonavir Nirmatrelvir/ritonavir Nirmatrelvir

Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China

N/A

Evusheld(AZD7442) is a combination of 2 human long-acting antibodies, which...

Status

Completed

Location

(2) Ruijin-Hainan Hospital Shanghai Jiaotong University School of Medicine (Hainan Boao Research Hospital)

Start Date

2022-12-24

Trial ID

NCT05917951

Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

PHASE3

* Research Question: Does convalescent plasma (CCP) collected from donors w...

Status

Terminated

Location

CHU Besançon

Start Date

2022-04-01

Trial ID

NCT05271929

Treatments Being Tested

Current standard of care and COVID-19 convalescent and vaccinated plasma Current standard of care

eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services

N/A

An AstraZeneca-sponsored observational, electronic healthcare record (EHR)-...

Status

Completed

Location

Research Site

Start Date

2023-03-09

Trial ID

NCT05712096

Treatments Being Tested

EVUSHELD

Previous Next